GLS and lung carcinoma: A publication that assessed in leukemia cells a lonidamine + DON combination, observed an increased anti-leukemia effect when both inhibitors are used together28, and similar effects were observed in lung cancer cells, with the combination of lonidamine and the glutaminase inhibitor 96829.